National Institute of Allergy and Infectious Diseases (NIAID): all 2,445 studies

Page 6 of 25. Open to participants first (182), then studies with results posted, then the rest; newest registration first within each.

• Evaluating the Safety and Effectiveness of Interferon-Free Treatment of Hepatitis C Virus Infection in HIV-Coinfected Adults on Antiretroviral TherapyTerminatedNCT02194998Phase 2Results posted
• Donor-Alloantigen-Reactive Regulatory T Cell (darTregs) in Liver TransplantationTerminatedNCT02188719Phase 1Results posted
• Evaluating the Safety, Tolerability, and Pharmacokinetics of an Investigational, Injectable HIV Medicine (GSK1265744) in HIV-Uninfected AdultsCompletedNCT02178800Phase 2Results posted
• Study to Evaluate Safety and Efficacy of Benralizumab in Subjects With Hypereosinophilic SyndromeStatus unknownNCT02130882Phase 2/3Results posted
• Elite Controller and ART-treated HIV+ Statin Versus ASA Treatment Intervention StudyCompletedNCT02081638Phase 2Results posted
• Nitazoxanide Versus Placebo for the Treatment of Hospitalized Subjects With Severe Acute Respiratory IllnessCompletedNCT02057757Phase 2Results posted
• BMT and High Dose Post-Transplant Cyclophosphamide for Chimerism Induction and Renal Allograft ToleranceTerminatedNCT02029638Phase 2Results posted
• Efficacy of Ustekinumab Followed by Abatacept for the Treatment of Psoriasis VulgarisCompletedNCT01999868Phase 2Results posted
• Evaluation of Anti-Hemagglutinin (Anti-HA) Antibodies as Protection From the Flu in Healthy PeopleCompletedNCT01971255Phase 1/2Results posted
• Evaluation of Oral Activated Charcoal on Antimalarial Drug's Ability to Kill Parasites in Malian Children With MalariaCompletedNCT01955382Phase 2Results posted
• Trichuris Suis Ova Treatment in Left-sided Ulcerative ColitisTerminatedNCT01953354Phase 2Results posted
• Safety and Effectiveness of Low-Dose Methotrexate for Reducing Inflammation in HIV-Infected Adults on ARV MedicationsCompletedNCT01949116Phase 2Results posted
• Randomized MMF Withdrawal in Systemic Lupus Erythematosus (SLE)TerminatedNCT01946880Phase 2Results posted
• Defining Immune Tolerance in ANCA-associated Vasculitis (AAV)TerminatedNCT01934504Results posted
• Evaluating the Safety and Efficacy of Romidepsin in Combination With Antiretroviral Therapy in HIV-Infected Adults With Suppressed Viral LoadCompletedNCT01933594Phase 1/2Results posted
• Systems Biology of Influenza A (H5N1) Virus Monovalent Vaccine With and Without Adjuvant System 03 (AS03)CompletedNCT01910519Phase 2Results posted
• Peanut Epicutaneous Phase II Immunotherapy Clinical TrialCompletedNCT01904604Phase 2Results posted
• Study of A Combination Pill With GS-7977 and GS-5885 for Hepatitis C in People With HIVCompletedNCT01878799Phase 2Results posted
• Peanut Oral Immunotherapy in ChildrenCompletedNCT01867671Phase 2Results posted
• Therapeutic Vaccine for HIVCompletedNCT01859325Phase 1Results posted
• Open-Label Phase 2 Trial of a Steroid-Free, CNI-Free, Belatacept-Based Immunosuppressive RegimenTerminatedNCT01856257Phase 2Results posted
• Idebenone for Primary Progressive Multiple SclerosisCompletedNCT01854359Phase 1/2Results posted
• Evaluating the Safety and Pharmacokinetics of Raltegravir in InfantsCompletedNCT01828073Results posted
• Phase II Trial to Assess Safety and Immunogenicity of IMVAMUNE®CompletedNCT01827371Phase 2Results posted
• Safety and Efficacy of Mupirocin in Eradicating Colonization With S. Aureus in Critically Ill InfantsCompletedNCT01827358Phase 2Results posted
• Combination Therapy for Chronic Hepatitis C InfectionCompletedNCT01805882Phase 2Results posted
• Optimization of NULOJIX® Usage Towards Minimizing CNI Exposure in Simultaneous Pancreas and Kidney TransplantationTerminatedNCT01790594Phase 2Results posted
• Safety and Pharmacokinetics of Raltegravir in HIV-1-Exposed Newborn Infants at Risk of Acquiring HIV-1 InfectionCompletedNCT01780831Phase 1Results posted
• Safety and Efficacy of Desensitization Therapy in Sensitized Participants Awaiting Heart TransplantationTerminatedNCT01769443Phase 2Results posted
• Safety, Tolerance and Pharmacokinetics of Raltegravir-Containing Antiretroviral Therapy in Infants, Children Infected With HIV and TBCompletedNCT01751568Phase 1/2Results posted
• Atopic Dermatitis Research Network (ADRN) Influenza Vaccine StudyCompletedNCT01737710Not applicableResults posted
• Tdap Vaccine in Post-Partum WomenCompletedNCT01711645Phase 4Results posted
• Vitamin D3 Treatment in Pediatric Systemic Lupus ErythematosusTerminatedNCT01709474Phase 2Results posted
• A Phase IIb, Open-Label, Dose Ranging Study of 13-Valent Pneumococcal Conjugate Vaccine in Adults 55 Through 74 Years of Age Previously Vaccinated With 23-Valent Pneumococcal Polysaccharide VaccineCompletedNCT01654263Phase 2Results posted
• Valganciclovir Therapy in Infants and Children With Congenital CMV Infection and Hearing LossCompletedNCT01649869Phase 2Results posted
• Influenza A 2009 H1N1 Challenge Study in Healthy AdultsCompletedNCT01646138Phase 1/2Results posted
• Assessment of the Immunogenicity and Safety of a Dose-Sparing BioThrax® AVA ScheduleCompletedNCT01641991Phase 4Results posted
• Immunosuppression Withdrawal for Stable Pediatric Liver Transplant RecipientsCompletedNCT01638559Phase 2Results posted
• Assessment of Pre-Exposure Prophylaxis (PrEP) Administered at Sexually Transmitted Disease (STD) ClinicsCompletedNCT01632995Not applicableResults posted
• The SCOUT Study: "Short Course Therapy for Urinary Tract Infections in Children"CompletedNCT01595529Phase 2Results posted
• Post-treatment Effects of Ivermectin (IVM) or Diethylcarbamazine (DEC) in LoiasisCompletedNCT01593722Phase 4Results posted
• Immune Responses to H5N1 Vaccine With and Without AS03 AdjuvantCompletedNCT01578317Phase 1/2Results posted
• Baminercept, a Lymphotoxin-Beta Receptor Fusion Protein, for Treatment of Sjögren's SyndromeTerminatedNCT01552681Phase 2Results posted
• CMV Antiviral Prevention Strategies in D+R-Liver Transplants ("CAPSIL")CompletedNCT01552369Phase 4Results posted
• Steroid Treatment for Hypereosinophilic SyndromeCompletedNCT01524536Phase 4Results posted
• Immune Monitoring and CNI Withdrawal in Low Risk Recipients of Kidney TransplantationTerminatedNCT01517984Phase 2Results posted
• Evaluating the Safety and Tolerability of Antiretroviral Drug Regimens Used as Pre-Exposure Prophylaxis to Prevent HIV Infection in At-Risk Men Who Have Sex With Men and in At-Risk WomenCompletedNCT01505114Phase 2Results posted
• Evaluating the Safety and Tolerability of Etravirine in HIV-1 Infected Infants and ChildrenCompletedNCT01504841Phase 1/2Results posted
• Evaluating the Safety of Immediate Versus Deferred Isoniazid Preventive Therapy Among HIV-Infected Pregnant WomenCompletedNCT01494038Phase 4Results posted
• A Study to Determine the Immunogenicity and Oral Tolerance to Keyhole Limpet Hemocyanin (KLH)TerminatedNCT01489956Early Phase 1Results posted
• Chikungunya Virus Vaccine Trial in Healthy AdultsCompletedNCT01489358Phase 1Results posted
• Evaluating the Effectiveness of Boceprevir, Pegylated-Interferon Alfa 2b and Ribavirin in Treating Hepatitis C Virus (HCV) Infection in Adults With HIV and HCV InfectionCompletedNCT01482767Phase 3Results posted
• Quadrivalent HPV Vaccine to Prevent Anal HPV in HIV-infected Men and WomenCompletedNCT01461096Phase 3Results posted
• Boceprevir Drug Combination for Hepatitis C Treatment in People With and Without HIVTerminatedNCT01443923Phase 4Results posted
• Chloroquine for Malaria in PregnancyCompletedNCT01443130Phase 3Results posted
• GS-7977 With Ribavirin for Hepatitis C (SPARE)CompletedNCT01441180Phase 1/2Results posted
• TIV and High Dose TIV in Subjects With Rheumatoid ArthritisCompletedNCT01436370Phase 2Results posted
• Staged Phase I/II Hepatitis C Prophylactic VaccineCompletedNCT01436357Phase 1/2Results posted
• Optimization of NULOJIX® Usage As A Means of Avoiding CNI and Steroids in Renal TransplantationTerminatedNCT01436305Phase 2Results posted
• Preventative Omalizumab or Step-up Therapy for Severe Fall ExacerbationsCompletedNCT01430403Phase 4Results posted
• Brief Rifapentine-Isoniazid Evaluation for TB Prevention (BRIEF TB)CompletedNCT01404312Phase 3Results posted
• Biomarkers of Cockroach Sublingual Immunotherapy 2CompletedNCT01380327Phase 1/2Results posted
• Persistence of Oral Tolerance to PeanutCompletedNCT01366846Phase 2Results posted
• Research Study of ATG and Rituximab in Renal TransplantationTerminatedNCT01318915Early Phase 1Results posted
• Evaluating the Use of Oseltamivir for the Treatment of Influenza in AdultsCompletedNCT01314911Not applicableResults posted
• Safety of and Immune Response to Dolutegravir in HIV-1 Infected Infants, Children, and AdolescentsCompletedNCT01302847Phase 1/2Results posted
• Safety Evaluation of an Experimental Treatment, Intradermal Human Fcγ1-Fel d1 Fusion Protein (GFD), for Cat AllergyTerminatedNCT01292070Early Phase 1Results posted
• Prevention of Cardiac Allograft Vasculopathy Using Rituximab (Rituxan) Therapy in Cardiac TransplantationTerminatedNCT01278745Phase 2Results posted
• Safety and Immunogenicity of Sequential Rotavirus Vaccine SchedulesCompletedNCT01266850Phase 4Results posted
• Topical Metronidazole and Miconazole Co-formulated Vaginal Suppositories for Preventing Vaginal Infections in HIV-seronegative WomenCompletedNCT01230814Phase 2Results posted
• Comparing the Efficacy, Safety, and Tolerability of Combination Antivirals (Amantadine, Ribavirin, Oseltamivir) Versus Oseltamivir for the Treatment of Influenza in Adults at Risk for ComplicationsCompletedNCT01227967Phase 2Results posted
• Development of Cockroach Immunotherapy by the Inner-City Asthma ConsortiumCompletedNCT01221285Phase 1Results posted
• A Research Trial of Aralast in New Onset Diabetes (RETAIN)TerminatedNCT01183468Phase 1Results posted
• Open Label Study to Evaluate Chronic Hepatitis C Treatment in Latino Subjects With and Without HIV Co-infectionTerminatedNCT01182298Results posted
• Post-Partum Immunization With Live Attenuated Influenza Vaccine (LAIV) or Trivalent Influenza Vaccine (TIV) in Post-Partum Breast Feeding WomenCompletedNCT01181323Phase 2Results posted
• 2010-2011 Trivalent Influenza Vaccine (TIV) in Pregnant WomenCompletedNCT01173211Phase 2Results posted
• A Phase II/III Trial of Lopinavir/Ritonavir Dosed According to the WHO Pediatric Weight Band Dosing GuidelinesCompletedNCT01172535Phase 2/3Results posted
• Biochemical Response to Interferon-Gamma in Subjects With Specific Gene Mutation in Chronic Granulomatous DiseaseTerminatedNCT01147042Phase 4Results posted
• A Cooperative Clinical Study of Abatacept in Multiple SclerosisCompletedNCT01116427Phase 2Results posted
• Reslizumab to Prevent Post-treatment Eosinophilia in LoiasisCompletedNCT01111305Phase 2Results posted
• Rituximab for Treatment of Systemic Sclerosis-Associated Pulmonary Arterial Hypertension (SSc-PAH)CompletedNCT01086540Phase 2Results posted
• Empiric Therapy of Mucopurulent Cervicitis (MPC)TerminatedNCT01072136Phase 3Results posted
• Evaluating Strategies to Reduce Mother-to-Child Transmission of HIV Infection in Resource-Limited CountriesCompletedNCT01061151Phase 3Results posted
• Safety and Efficacy of Investigational Anti-Influenza Immune Plasma in Treating InfluenzaCompletedNCT01052480Phase 2Results posted
• Vaccine Study for Tick-Borne Encephalitis Virus (TBEV)TerminatedNCT01031537Phase 2Results posted
• Alloantibodies in Pediatric Heart TransplantationTerminatedNCT01005316Results posted
• Safety of and Immune Response to an H1N1 Influenza Virus Vaccine in HIV Infected Children and YouthCompletedNCT00992836Phase 2Results posted
• Novartis H1N1 Vaccine in Pregnant WomenCompletedNCT00992719Phase 2Results posted
• H1N1 Vaccine at Two Dose Levels in HIV Positive AdultsCompletedNCT00992433Phase 2Results posted
• Safety of and Immune Response to an H1N1 Influenza Vaccine in HIV Infected Pregnant WomenCompletedNCT00992017Phase 2Results posted
• Nitazoxanide Plus Ribavirin and Peginterferon for Therapy of Treatment Naive HCV Genotype 1 and HIV Coinfected SubjectsCompletedNCT00991289Phase 2Results posted
• Treatment Failure of Chlamydial Infection in Males and Females in Youth Correctional FacilitiesCompletedNCT00980148Phase 3Results posted
• Safety and Efficacy of an H1N1 Influenza Vaccine in People With AsthmaCompletedNCT00978120Phase 2Results posted
• Inducing Remission in Type 1 Diabetes With AlefaceptTerminatedNCT00965458Phase 2Results posted
• H1N1 Vaccine in Pregnant WomenCompletedNCT00963430Phase 2Results posted
• Sanofi H1N1 Influenza Vaccine Administered at Different Dose Levels With and Without AS03 Adjuvant in Healthy Adult and Elderly PopulationsCompletedNCT00963157Phase 2Results posted
• Clinical Trial of Idebenone in Primary Progressive Multiple Sclerosis (IPPoMS)CompletedNCT00950248Phase 1/2Results posted
• Peds Sanofi H1N1 Influenza Vaccine Administered at Two Dose LevelsCompletedNCT00944073Phase 2Results posted
• Sanofi H1N1 + TIV - Adults and ElderlyCompletedNCT00943878Phase 2Results posted
• Sanofi H1N1 Influenza Vaccine Administered at Two Dose Levels in Adult and Elderly PopulationsCompletedNCT00943631Phase 2Results posted

← National Institute of Allergy and Infectious Diseases (NIAID) overview and focus areas